Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
san francisco blog main
3
×
san francisco top stories
startups
biogen
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
general atlantic
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
What
medicines
3
×
bio
covid
ipo
new
roundup
acquisitions
activity
aim
announced
approvals
biogen
boost
cancer
ceo
change
clamped
collabs
community
daniel
deal
delays
developing
diagnostics
docs
economic
fast
fda
flatiron
gilead
gilead’s
help
helped
immunotherapy
including
introduce
isn’t
lot
month
number
Language
unset
Current search:
medicines
×
cancer
×
" san francisco blog main "
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care